ELTX:NASDAQ
Elicio Therapeutics Inc
US$1,98
arrow_downward
-1,00%(-0,020) 1D
15 ກ.ຍ., 10 ໂມງ 57 ນາທີ 23 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELTX...
Open
US$2,01
High
US$2,01
Low
US$1,92
Mkt. cap
໕໒,໐໔ ລ້ານ
Avg. vol.
໓໐໘,໙໗ ພັນ
Volume
໖໕,໕໑ ພັນ
52-wk high
US$16,00
52-wk low
US$1,92
EPS
US$-2,18
Beta
໑,໒໙
Shares outstanding
໒໖,໒໘ ລ້ານ
No. of employees
໓໓
Open
US$2,01
High
US$2,01
Low
US$1,92
Mkt. cap
໕໒,໐໔ ລ້ານ
Avg. vol.
໓໐໘,໙໗ ພັນ
Volume
໖໕,໕໑ ພັນ
52-wk high
US$16,00
52-wk low
US$1,92
EPS
US$-2,18
Beta
໑,໒໙
Shares outstanding
໒໖,໒໘ ລ້ານ
No. of employees
໓໓
News stories
From web sources and news partners
Investing.com
·
17 ຊົ່ວໂມງກ່ອນ
Elicio Therapeutics at H.C. Wainwright: pivot to metastatic cancer
TipRanks
·
18 ຊົ່ວໂມງກ່ອນ
Elicio Therapeutics Sets Key 2026 Shareholder Proposal Deadlines
Stock Titan
·
18 ຊົ່ວໂມງກ່ອນ
Elicio Therapeutics (ELTX) sets Sept. 24 cutoff for 2026 proxy proposals
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
Headquartersບອສຕັນ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websiteelicio.com